Barclays’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $392K | Sell |
160,846
-481,841
| -75% | -$966K | ﹤0.01% | 3325 |
|
|
2025
Q4 | $880K | Buy |
642,687
+43,690
| +7% | +$57.6K | ﹤0.01% | 3525 |
|
|
2025
Q3 | $743K | Sell |
598,997
-46,328
| -7% | -$55.2K | ﹤0.01% | 3551 |
|
|
2025
Q2 | $729K | Sell |
645,325
-10,066
| -2% | -$13.4K | ﹤0.01% | 3539 |
|
|
2025
Q1 | $957K | Sell |
655,391
-105,895
| -14% | -$200K | ﹤0.01% | 3135 |
|
|
2024
Q4 | $1.62M | Buy |
761,286
+418,313
| +122% | +$1.03M | ﹤0.01% | 3057 |
|
|
2024
Q3 | $960K | Buy |
342,973
+172,745
| +101% | +$461K | ﹤0.01% | 3382 |
|
|
2024
Q2 | $397K | Buy |
170,228
+13,481
| +9% | +$39.8K | ﹤0.01% | 3189 |
|
|
2024
Q1 | $701K | Sell |
156,747
-28,160
| -15% | -$118K | ﹤0.01% | 3370 |
|
|
2023
Q4 | $594K | Sell |
184,907
-601,886
| -76% | -$1.71M | ﹤0.01% | 3774 |
|
|
2023
Q3 | $2.49M | Buy |
786,793
+117,596
| +18% | +$515K | ﹤0.01% | 1749 |
|
|
2023
Q2 | $3.33M | Buy |
669,197
+168,546
| +34% | +$912K | ﹤0.01% | 1591 |
|
|
2023
Q1 | $2.47M | Buy |
500,651
+77,598
| +18% | +$498K | ﹤0.01% | 2041 |
|
|
2022
Q4 | $2.66M | Buy |
423,053
+105,287
| +33% | +$975K | ﹤0.01% | 2053 |
|
|
2022
Q3 | $3.43M | Buy |
317,766
+287,087
| +936% | +$3.9M | ﹤0.01% | 1393 |
|
|
2022
Q2 | $350K | Sell |
30,679
-73,692
| -71% | -$654K | ﹤0.01% | 3100 |
|
|
2022
Q1 | $951K | Buy |
104,371
+4,039
| +4% | +$42.1K | ﹤0.01% | 2450 |
|
|
2021
Q4 | $1.5M | Buy |
100,332
+56,582
| +129% | +$998K | ﹤0.01% | 2560 |
|
|
2021
Q3 | $1.12M | Sell |
43,750
-52,184
| -54% | -$1.24M | ﹤0.01% | 2719 |
|
|
2021
Q2 | $2.5M | Sell |
95,934
-33,584
| -26% | -$958K | ﹤0.01% | 2048 |
|
|
2021
Q1 | $4.57M | Buy |
129,518
+68,113
| +111% | +$2.3M | ﹤0.01% | 1592 |
|
|
2020
Q4 | $1.55M | Sell |
61,405
-17,899
| -23% | -$583K | ﹤0.01% | 2442 |
|
|
2020
Q3 | $2.99M | Sell |
79,304
-9,307
| -11% | -$351K | ﹤0.01% | 1768 |
|
|
2020
Q2 | $3.79M | Buy |
88,611
+26,629
| +43% | +$963K | ﹤0.01% | 1576 |
|
|
2020
Q1 | $1.2M | Buy |
61,982
+13,896
| +29% | +$331K | ﹤0.01% | 2766 |
|
|
2019
Q4 | $1.25M | Buy |
48,086
+16,197
| +51% | +$446K | ﹤0.01% | 3474 |
|
|
2019
Q3 | $870K | Buy |
31,889
+6,883
| +28% | +$196K | ﹤0.01% | 3790 |
|
|
2019
Q2 | $671K | Sell |
25,006
-5,005
| -17% | -$139K | ﹤0.01% | 4075 |
|
|
2019
Q1 | $868K | Buy |
30,011
+29,027
| +2,950% | +$842K | ﹤0.01% | 3559 |
|
|
2018
Q4 | $27K | Buy |
+984
| New | +$26.1K | ﹤0.01% | 5767 |
|
Other funds holding ALLO
P
TGA
VCM
